Logan Capital Management Inc Guardant Health, Inc. Transaction History

Logan Capital Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$28.82 - $77.35 $1,527 - $4,099	-53 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$88.71 - $120.43 $4,346 - $5,901	-49 Reduced 48.04%	53 $5,000
Q2 2021 Aug 17, 2021	BUY	$109.77 - $165.68 $11,196 - $16,899	102 New	102 $13,000
Q2 2021 Aug 17, 2021	SELL	$109.77 - $165.68 $11,196 - $16,899	-102 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$127.04 - $179.1 $12,958 - $18,268	102 New	102 $16,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.12B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Logan Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Logan Capital Management Inc with notifications on news.